(RTTNews) - A report released by the Commerce Department on Wednesday showed a sharp increase in new residential construction in the U.S. in the month of December.
(RTTNews) - A report released by the Commerce Department on Wednesday showed a sharp increase in new residential construction in the U.S. in the month of December.
Image source: The Motley Fool. Wednesday, February 18, 2026 at 9:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Image source: The Motley Fool. Wednesday, February 18, 2026 at 9:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
wildpixel/iStock via Getty Images ImmunityBio ( IBRX ) traded higher on Wednesday after the European Commission issued a conditional marketing authorization for its bladder cancer therapy, Anktiva, expanding its use in more than two dozen EU countries. The decision came after an expert panel of the EU drug regulator, the European Medicines Agency, endorsed the immunotherapy in December as part of ...
wildpixel/iStock via Getty Images ImmunityBio ( IBRX ) traded higher on Wednesday after the European Commission issued a conditional marketing authorization for its bladder cancer therapy, Anktiva, expanding its use in more than two dozen EU countries. The decision came after an expert panel of the EU drug regulator, the European Medicines Agency, endorsed the immunotherapy in December as part of a combination regimen for a type of invasive bladder cancer. Specifically, the authorization allows the company to market Anktiva across 27 countries in combination with Bacillus Calmette-Guérin (BCG) for adults with BCG-unresponsive non-muscle invasive bladder cancer. As part of the condition approval, which was based on IBRX’s Phase 2/3 QUILT-3.032 study, ImmunityBio ( IBRX ) is required to provide EU regulators with long-term safety and efficacy data related to Anktiva . More on ImmunityBio ImmunityBio: The Story Surrounding Anktiva So Far ImmunityBio: Making Strides, But Beware The Hype (Rating Downgrade) ImmunityBio, Inc. (IBRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ImmunityBio rally causes $492M paper losses for short sellers ImmunityBio extends gains after FDA views on Anktiva label expansion
For the most part, analysts across Wall Street maintained their long-term bullishness on shares of Cadence Design Systems , following its fourth-quarter earnings release, calling threats of artificial intelligence disruption overblown. On Tuesday afternoon, the electronic systems designer reported fourth-quarter adjusted earnings of $1.99 per share, surpassing the $1.91 analysts polled by FactSet ...
For the most part, analysts across Wall Street maintained their long-term bullishness on shares of Cadence Design Systems , following its fourth-quarter earnings release, calling threats of artificial intelligence disruption overblown. On Tuesday afternoon, the electronic systems designer reported fourth-quarter adjusted earnings of $1.99 per share, surpassing the $1.91 analysts polled by FactSet had expected. Cadence's $1.44 billion revenue also exceeded the consensus forecast of $1.42 billion. Cadence estimated full-year earnings will also come in higher than anticipated. Revenue for its current quarter should land between $1.42 billion and $1.46 billion, above analysts' expectations of $1.38 billion. Cadence has been swept up in the broader software sell-off this year, with the stock down 9% in 2026. But shares were already rebounding 7% higher as analysts applauded Cadence's protection from AI threats. "While there are general concerns about AI disrupting the software business model, both we and the team believe that chip design software is highly complex and not easily replicated, benefiting from strong technology, a strong customer/ ecosystem network, and a significant data moat. Instead, AI should enable Cadence to unlock better automation capabilities for customers and drive improved monetization," JPMorgan analyst Harlan Sur wrote. "Cadence noted agentic AI workflows at customers are increasing the use of its software and is not engaged in customer discussions to reduce [electronic design automation]. Cadence is adding extra tools to automate the [register transfer level] coding process (manual), while noting the chip design process still requires existing tools such as verification, simulation, etc," wrote Wells Fargo analyst Joe Quatrochi. "We would view this positively, and we'll be interested in better understanding Cadence's 'usage / outcome-based' pricing of its AI tools." Bottom line, most analysts maintained their long-term bullish stance, although ...
Treasury spokesperson says disability benefits would also be limited under Reform, but Bank of England would stay independent UK politics live – latest updates Reform UK would restore the two-child benefit cap in full, Robert Jenrick has announced, in a major U-turn for the party that critics said would plunge hundreds of thousands of children into poverty. In his first speech as Reform’s Treasury...
Treasury spokesperson says disability benefits would also be limited under Reform, but Bank of England would stay independent UK politics live – latest updates Reform UK would restore the two-child benefit cap in full, Robert Jenrick has announced, in a major U-turn for the party that critics said would plunge hundreds of thousands of children into poverty. In his first speech as Reform’s Treasury spokesperson, Jenrick said the party had changed tack since Nigel Farage last year said he would scrap the two-child limit and suggested his party wanted to go “much further to encourage people to have children”. Continue reading...
The highly-anticipated IPO boom may take a little longer to materialize as the market for new issuances limped into a seasonal quiet period. Postponed listings from broker Clear Street Group Inc. and Blackstone Inc. -backed Liftoff Mobile Inc. and broader stock market volatility left a sour taste in growth investors’ mouths as the window for initial public offerings before annual audits came to an...
The highly-anticipated IPO boom may take a little longer to materialize as the market for new issuances limped into a seasonal quiet period. Postponed listings from broker Clear Street Group Inc. and Blackstone Inc. -backed Liftoff Mobile Inc. and broader stock market volatility left a sour taste in growth investors’ mouths as the window for initial public offerings before annual audits came to an end last week. The jolt of delayed deals paired with choppy performances across the class of 2026 kept a lid on what’s been the busiest start to a year since the go-go days of 2021. “I’m pleased with activity levels, not necessarily the outcomes, but activity levels,” said Mark Schwartz , who leads IPO and SPAC advisory at consulting giant EY. Read More: Slashed Valuations, Postponed Deal Puncture US IPO Optimism US first-time share sales raised roughly $7.2 billion through Feb. 17, the most since the market brought in about five-times that in 2021’s mania, with 16 deals for more than $100 million in the best burst in five years, data compiled by Bloomberg show. The performance of deals has been mixed, however, with roughly half of such deals trading below their offering price. The rocky start to the year for debutants burned tech buyers while companies in sectors that are insulated from the threat of artificial intelligence — like industrials and consumer — have performed far better. The volatility whipped up by an opaque outlook for AI’s impact across industries has driven a 1.2% decline on the benchmark S&P 500 Index this month with the tech-heavy Nasdaq 100 lower by 3.1%. While the weighted-average return of US IPOs this year is 17%, notably outpacing headline equity benchmarks, four companies have erased at least 15% of their value. Ethos Technologies Inc. , which has crashed 45% in three weeks, and Bitgo Holdings Inc. , down 41% in less than a month, have been among the worst performers. “What may be is missing is a bit of FOMO,” said Dan Klausner , head of US public...
Getty Images Dear Gator Partners: We are pleased to provide you with Gator Financial Partners, LLC's, Gator Offshore Partners, Ltd.'s, and Gator Qualified Partners, LLC's (the "Funds") 2025 4 th quarter investor letter. This letter reviews the Fund's 2025 Q4 and shares our investment thesis on TFS Financial Corporation ( TFSL ). Review of Q4 & 2025 Performance During the 4 th quarter of 2025, the ...
Getty Images Dear Gator Partners: We are pleased to provide you with Gator Financial Partners, LLC's, Gator Offshore Partners, Ltd.'s, and Gator Qualified Partners, LLC's (the "Funds") 2025 4 th quarter investor letter. This letter reviews the Fund's 2025 Q4 and shares our investment thesis on TFS Financial Corporation ( TFSL ). Review of Q4 & 2025 Performance During the 4 th quarter of 2025, the Funds had solid performance. We outperformed both the broader market and the Financials sector benchmark. The Fund's holdings in small and mid-cap Financials outperformed the largest bank and insurance companies again this quarter. Our long positions in Anywhere Real Estate (HOUS), Societe Generale ( SCGLY ), First Citizens Bancshares ( FCNCA ), Customers Bancorp ( CUBI ), and Sotherly Hotels (SOHO) were the top contributors to the Fund's performance. The largest detractors were long positions in Virtus Investment Partners ( VRTS ), Global Payments ( GPN ), and PayPal ( PYPL ), and short positions on TD Bank ( TD ) and Citigroup ( C ). 2025 Q4 2025 YTD Total ReturnSince Inception 1 Annualized ReturnSince Inception 1 Gator Financial Partners, LLC 2 4.14% 31.94% 3,229.88% 22.18% S&P 500 Total Return Index 3 2.65% 17.88% 649.23% 12.20% S&P 1500 Financials Index 3 1.95% 14.34% 384.47% 9.44% Gator Offshore Partners, Ltd. 2 3.96% 30.90% 394.32% 14.57% S&P 500 Total Return Index 3 2.65% 17.88% 350.91% 13.68% S&P 1500 Financials Index 3 1.95% 14.34% 273.98% 11.88% Gator Qualified Partners, LLC 2 6.10% 16.92% 16.92% S&P 500 Total Return Index 3 2.65% 11.00% 11.00% S&P 1500 Financials Index 3 1.95% 5.41% 5.41% Source: Gator Capital Management & Bloomberg Click to enlarge During 2025, we had strong performance and outperformed both the broader market and the Financials sector benchmark. The two major drivers were our positions in Robinhood Markets ( HOOD ) and Anywhere Real Estate. We entered 2025 with Robinhood as our largest position after it had a strong 2024. The stock had another...
The rapid deployment of data centers for artificial intelligence has revived nuclear power as a viable electricity source in the United States. NuScale Power (NYSE: SMR) sits in a unique position as the only nuclear energy stock with a small modular reactor (SMR) design approved by the U.S. Nuclear Regulatory Commission. Small nuclear reactors offer exciting investment potential because they are l...
The rapid deployment of data centers for artificial intelligence has revived nuclear power as a viable electricity source in the United States. NuScale Power (NYSE: SMR) sits in a unique position as the only nuclear energy stock with a small modular reactor (SMR) design approved by the U.S. Nuclear Regulatory Commission. Small nuclear reactors offer exciting investment potential because they are less expensive, easier to build, and more compact than traditional nuclear reactors. Yet, NuScale Power stock hasn't fared well, declining by nearly 40% over the past year. Is the stock a buy now? Here is why investors may struggle to pull the trigger here. Continue reading
Kind Hearts and Coronets gets a slick, Glen Powell-led remix that’s stylishly made but entirely redundant There’s solid, if soulless, on-paper thinking behind the existence of How to Make a Killing, decisions one can imagine getting some enthused whoops inside an LA conference room. We have IP (beloved Ealing comedy Kind Hearts and Coronets), a Black List script (originally titled Rothchild back i...
Kind Hearts and Coronets gets a slick, Glen Powell-led remix that’s stylishly made but entirely redundant There’s solid, if soulless, on-paper thinking behind the existence of How to Make a Killing, decisions one can imagine getting some enthused whoops inside an LA conference room. We have IP (beloved Ealing comedy Kind Hearts and Coronets), a Black List script (originally titled Rothchild back in 2014), a man-of-the-moment lead (the ubiquitous Glen Powell), a woman-of-the-moment co-star (the equally ubiquitous Margaret Qualley), an of-the-moment trend (eat the rich), an indie company turned merch-able brand (A24) and a film-maker who recently broke out with a buzzed-about debut (Emily the Criminal’s John Patton Ford). If ChatGPT were to create an AI service for studio execs, this would be an obvious green light. But when dragged into the real world, of discernment and taste, it’s a package that brings up a string of concerning questions. Can Powell pull off burgeoning murderous psychopath? Is it time to stop relying on the Black List as a taste test for quality? Has eat the rich fatigue set in? And, most importantly, why on earth would one try to remake a close-to-perfect classic? Continue reading...